NEW YORK (GenomeWeb News) - Alnylam Pharmaceuticals said yesterday that it has closed its previously announced strategic alliance with Roche under which Roche agreed to license an Alnylam RNAi therapeutic technology platform and certain intellectual property, acquire one of Alnylam’s labs, and work with the firm on drug-discovery projects.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A draft bill released by the US House of Representatives appropriations committee would increase the 2019 National Institutes of Health budget by 3 percent.

NBC News reports on the Earth BioGenome Project, which aims to sequence all eukaryotic life on Earth.

Bloomberg looks into privacy issues raised by law enforcement's use of genetic genealogy sites.

In Science this week: environmental DNA can help in studies of marine animals, and more.